Top Markets
Coin of the day
SpyGlass Pharma, Inc. Common Stock SpyGlass Pharma, Inc. Common Stock

SpyGlass Pharma, Inc. Common Stock

SGP
Classifica tra le azioni #10213
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to... SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.
Prezzo delle azioni
$26.13
Ultima sincronizzazione: 2026-08-28
Capitalizzazione di mercato
$873.45M
Variazione (1 giorno)
-2.99%
Variazione (1 anno)
-
Paese
US
Scambia SpyGlass Pharma, Inc. Common Stock (SGP)

Categoria

Storico del rendimento da dividendi per SpyGlass Pharma, Inc. Common Stock (SGP)
Il rendimento da dividendi (TTM) di SpyGlass Pharma, Inc. Common Stock (simbolo azionario: SGP) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per SpyGlass Pharma, Inc. Common Stock (SGP) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
3.12%
AU
0.00%
US
0.00%
CH